ELHAM ARMAH: Open Payments
NPI 1851718381 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 12 payments from 6 companies in 2025. Trend: 2023 $651 · 2024 $1,099 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $302 |
| Axsome Therapeutics, Inc. | 2 | $185 |
| Lilly USA, LLC | 2 | $110 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: Wegovy, Auvelity, ZEPBOUND, Ozempic, PIFELTRO, MOUNJARO, VRAYLAR, INGREZZA.
Industry payments across AR — which companies pay providers there.
